Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
46
SRPT Quote, Financials, Valuation and Earnings
Last price:
$21.99
Seasonality move
:
29.39%
Day range:
$17.84 - $18.54
52-week range:
$16.88 - $150.48
Dividend yield:
0%
P/E ratio:
20.50x
P/S ratio:
0.91x
P/B ratio:
1.58x
Volume:
13M
Avg. volume:
6.8M
1-year change:
-87.66%
Market cap:
$1.8B
Revenue:
$1.9B
EPS (TTM):
-$2.69
Earnings Data
Next earnings date for SRPT
Aug 07
2025
Most recent earnings per share
-$4.60
Missed by $3.95
(May 6/2025)
Consensus Estimate
-$0.65
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SRPT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $484.9M | -- | -- | $0.35 | -- |
| 08/07/2025 | Q2 | $530.7M | -- | -- | $1.13 | -- |
| 05/06/2025 | Q1 | $684.1M | $744.9M | -$4.60 | -$0.65 | -$3.95 |
| 02/26/2025 | Q4 | $631M | $658.4M | $1.50 | $2.06 | -$0.56 |
| 11/06/2024 | Q3 | $405.1M | $467.2M | $0.34 | $0.37 | -$0.03 |
| 08/07/2024 | Q2 | $387.3M | $362.9M | $0.07 | $0.47 | -$0.40 |
| 05/01/2024 | Q1 | $375.4M | $413.5M | $0.37 | $0.41 | -$0.04 |
| 02/28/2024 | Q4 | $386.2M | $396.8M | $0.76 | $0.37 | $0.39 |
| 11/01/2023 | Q3 | -- | -- | -$0.46 | -$0.49 | $0.03 |
| 08/02/2023 | Q2 | -- | -- | -$0.27 | -$1.00 | $0.73 |
| 05/02/2023 | Q1 | -- | -- | -$5.86 | -$0.83 | -$5.03 |
| 02/28/2023 | Q4 | -- | -- | -$1.24 | -$0.93 | -$0.31 |
| 11/02/2022 | Q3 | -- | -- | -$2.94 | -$0.74 | -$2.20 |
| 08/02/2022 | Q2 | -- | -- | -$2.65 | -$0.60 | -$2.05 |
| 05/04/2022 | Q1 | -- | -- | -$1.20 | -$1.03 | -$0.17 |
| 03/01/2022 | Q4 | -- | -- | -$1.43 | -$1.14 | -$0.29 |
| 11/03/2021 | Q3 | -- | -- | -$0.60 | -$1.52 | $0.92 |
| 08/04/2021 | Q2 | -- | -- | -$1.02 | -$1.29 | $0.27 |
| 05/05/2021 | Q1 | -- | -- | -$2.10 | -$1.57 | -$0.53 |
| 03/01/2021 | Q4 | -- | -- | -$2.41 | -$1.46 | -$0.95 |
| 11/05/2020 | Q3 | -- | -- | -$2.50 | -$1.40 | -$1.10 |
| 08/05/2020 | Q2 | -- | -- | -$1.93 | -$1.31 | -$0.62 |
| 05/06/2020 | Q1 | -- | -- | -$0.23 | $1.93 | -$2.16 |
| 02/26/2020 | Q4 | -- | -- | -$3.17 | -$1.27 | -$1.90 |
| 11/07/2019 | Q3 | -- | -- | -$1.70 | -$0.92 | -$0.78 |
| 08/07/2019 | Q2 | -- | -- | -$3.74 | -$0.77 | -$2.97 |
| 05/08/2019 | Q1 | -- | -- | -$1.07 | -$0.81 | -$0.26 |
| 02/27/2019 | Q4 | -- | -- | -$2.05 | -$0.73 | -$1.32 |
| 10/24/2018 | Q3 | -- | -- | -$1.15 | -$0.49 | -$0.66 |
| 08/08/2018 | Q2 | -- | -- | -$1.67 | -$0.33 | -$1.34 |
| 05/03/2018 | Q1 | -- | -- | -$0.55 | -- | -- |
| 03/01/2018 | Q4 | -- | -- | -$0.37 | -- | -- |
| 10/25/2017 | Q3 | -- | -- | -$0.78 | -- | -- |
| 07/19/2017 | Q2 | -- | -- | -$1.15 | -- | -- |
| 04/27/2017 | Q1 | -- | -- | $1.50 | -- | -- |
| 02/28/2017 | Q4 | -- | -- | -$1.62 | -- | -- |
| 10/27/2016 | Q3 | -- | -- | -$1.18 | -- | -- |
| 07/19/2016 | Q2 | -- | -- | -$1.35 | -- | -- |
| 05/05/2016 | Q1 | -- | -- | -$1.31 | -- | -- |
| 02/25/2016 | Q4 | -- | -- | -$1.44 | -- | -- |
| 11/05/2015 | Q3 | -- | -- | -$1.25 | -- | -- |
Sarepta Therapeutics Earnings Questions
-
How Much did Sarepta Therapeutics Generate in Revenue Last Quarter?
Sarepta Therapeutics reported $744.9M worth of top line sales in its most recent quarter.
-
Did Sarepta Therapeutics Beat Earnings Last Quarter?
Sarepta Therapeutics announced earnings per share of -$4.60 which represents a miss of analyst forecast a -$0.65 per share.
-
Is Sarepta Therapeutics Profitable?
Sarepta Therapeutics reported $607.3M that represents $6.24 per share over the last quarter.
-
What is the Analyst Consensus for Sarepta Therapeutics EPS Next Year?
Sarepta Therapeutics's earnings are forecast to decrease from $2.34 per share to $4.02 per share next year representing a decrease of -95.57%.
-
When is Sarepta Therapeutics's Earnings Date?
Sarepta Therapeutics's next earnings date is August 7, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
